Myeloproliferative Neoplasm(MPN)-Associated Myelofibrosis

Explore clinical trials studying Myeloproliferative Neoplasm(MPN)-Associated Myelofibrosis. Study availability and eligibility vary by location and protocol.

2 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

Myeloproliferative Neoplasm(MPN)-Associated Myelofibrosis trial results

Recruiting

A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials

NCT04064060

Conditions: Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +13 more
Locations: Local Institution - 968 Los Angeles, California, United States

Local Institution - 971 Oakland, California, United States

Local Institution - 978 Stanford, California, United States

Local Institution - 975 Tampa, Florida, United States

View all 143 locations

View Trial Details

Recruiting

MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs)

NCT07362225

Conditions: Accelerated Phase MPN, Accelerated Phase Myeloproliferative Neoplasm, Agnogenic Myeloid Metaplasia, +78 more
Locations: MPN Research Foundation Chicago, Illinois, United States

Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Myeloproliferative Neoplasm(MPN)-Associated Myelofibrosis

Myeloproliferative Neoplasm(MPN)-Associated Myelofibrosis trial results

A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials

MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs)

Related conditions